Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
9.58
+0.03 (0.31%)
At close: Aug 13, 2025, 4:00 PM
9.45
-0.13 (-1.36%)
After-hours: Aug 13, 2025, 6:38 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $308.43 million as of August 13, 2025. Its market cap has increased by 182.59% in one year.
Market Cap
308.43M
Enterprise Value
173.12M
1-Year Change
182.59%
Ranking
Category
Stock Price
$9.58
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $308.43M, a decrease of -13.07%. That is a compound annual growth rate of -6.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 307.47M | 112.22% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |